To assess hepatocellular carcinoma (HCC) survival and to investigate the prognostic role of immunonutritional biomarkers, as Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR) and Prognostic Nutritional Index (PNI), in a cohort of HIV-infected patients
Introduction: Simple indices derived from a blood count are useful as predictors of survival in both...
Background: Hepatocellular carcinoma (HCC) is a leading cause of liver-related mortality in people l...
Systemic inflammation is a key risk factor for hepatocellular carcinoma (HCC) progression and poor o...
Background: Hepatocellular carcinoma (HCC) is increasingly prevalent in people living with HIV. Syst...
BackgroundInflammation in human immunodeficiency virus (HIV)-infected patients is associated with po...
BACKGROUND: The systemic inflammatory response has been postulated as having prognostic significance...
Two biomarkers, the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), hav...
Background: Inflammation is a recognized concomitant of hepatocellular carcinoma (HCC) and its indic...
Background: Recently, some systemic inflammation-based biomarkers have been demonstrated useful for ...
BackgroundThe neutrophil-lymphocyte ratio (NLR), a presumed measure of the balance between neutrophi...
HIV, HTLV-1/-2, and HCV share routes of transmission, and such virus co-infections could account for...
Background/Aims: Systemic inflammatory response (SIR) is widely considered as a preoperative risk fa...
Background: Recently, some systemic inflammation-based biomarkers have been demonstrated useful for...
TACE plays a pivotal role in hepatocellular carcinoma, from disease control to downstaging and bridg...
BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of liver-related mortality in people l...
Introduction: Simple indices derived from a blood count are useful as predictors of survival in both...
Background: Hepatocellular carcinoma (HCC) is a leading cause of liver-related mortality in people l...
Systemic inflammation is a key risk factor for hepatocellular carcinoma (HCC) progression and poor o...
Background: Hepatocellular carcinoma (HCC) is increasingly prevalent in people living with HIV. Syst...
BackgroundInflammation in human immunodeficiency virus (HIV)-infected patients is associated with po...
BACKGROUND: The systemic inflammatory response has been postulated as having prognostic significance...
Two biomarkers, the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), hav...
Background: Inflammation is a recognized concomitant of hepatocellular carcinoma (HCC) and its indic...
Background: Recently, some systemic inflammation-based biomarkers have been demonstrated useful for ...
BackgroundThe neutrophil-lymphocyte ratio (NLR), a presumed measure of the balance between neutrophi...
HIV, HTLV-1/-2, and HCV share routes of transmission, and such virus co-infections could account for...
Background/Aims: Systemic inflammatory response (SIR) is widely considered as a preoperative risk fa...
Background: Recently, some systemic inflammation-based biomarkers have been demonstrated useful for...
TACE plays a pivotal role in hepatocellular carcinoma, from disease control to downstaging and bridg...
BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of liver-related mortality in people l...
Introduction: Simple indices derived from a blood count are useful as predictors of survival in both...
Background: Hepatocellular carcinoma (HCC) is a leading cause of liver-related mortality in people l...
Systemic inflammation is a key risk factor for hepatocellular carcinoma (HCC) progression and poor o...